Efficacy and Safety of Gefitinib in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials.

Tang, Xiaoxia; He, Juan; Li, Bo; Zheng, Yi; Li, Kejia; Zou, Shun; Chen, Long

Tang, Xiaoxia; He, Juan; Li, Bo; Zheng, Yi; Li, Kejia; Zou, Shun; Chen, Long.

Afiliação

Tang X; Department of Pharmacy, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
He J; Department of Pharmacy, The 920th Hospital of PLA, Kunming, Yunnan, China.
Li B; College of Pharmaceutical Sciences, Kunming Medical University, Kunming, China.
Zheng Y; Advanced Analytics Institute, University of Technology Sydney, Australia.
Li K; Department of Pharmacy, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zou S; Department of Pharmacy, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Chen L; Department of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.

J Oncol ; 2019: 6273438, 2019.

Article em En | MEDLINE | ID: mdl-31239839

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google